ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Preemptive CMV Prophylaxis in Renal Transplant Recipients Receiving Everolimus Immunosuppression Reduces Cytomegalovirus Infection.

    G. Spagnoletti, M. Salerno, V. Bianchi, N. Silvestrini, F. Apponi, J. Romagnoli.

    Surgery - Renal Transplant Unit, Università Cattolica del Sacro Cuore, Rome, Italy.

    Introduction.Aim of this study was to evaluate the efficacy and safety of preemptive prophylaxis of CMV infection in kidney transplant recipients (KTx) receiving polyclonal antibodies…
  • 2016 American Transplant Congress

    Quantiferon-CMV Test, CMV-Specific ELISPOT and CMV-Dextramer Assays in Assessing the Risk of CMV Infection in Seropositive Kidney Transplant Recipients.

    H. Lee,1 K. Park,2 J. Ryu,2 J. Yu,3 B. Chung,3 C. Yang,3 E.-J. Oh.1

    1Department of Laboratory Medicine, The Catholic University of Korea, Seoul, Korea; 2Department of Biomedical Science, Graduate School, The Catholic University of Korea, Seoul, Korea; 3Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea.

    Human cytomegalovirus (CMV) infection is one of the primary opportunistic pathogens and is a leading cause of morbidity and mortality in kidney transplant recipients. Assessing…
  • 2016 American Transplant Congress

    Reduced-Dose Cidofovir (CID) and CMV-Hyperimmune Globulin (CMVIg) for Ganciclovir-Resistant Cytomegalovirus: Effective and Kidney Friendly.

    S. Patel, S. Kuten, J. Snyder, R. Knight, A. Gaber.

    Houston Methodist Hospital, Houston, TX.

    Ganciclovir resistant (GR) CMV is associated with an aggressive disease course and substantial morbidity. Furthermore, treatment options such as foscarnet and cidofovir are incredibly nephrotoxic.…
  • 2016 American Transplant Congress

    Comparative Effectiveness of Cytomegalovirus Prevention Strategies in a Large Retrospective Cohort of Kidney Transplant Recipients.

    C. Santos, M. Saeed, D. Brennan, M. Olsen.

    Washington University School of Medicine, Saint Louis, MO.

    Background: While CMV prevention strategies have been studied in carefully selected groups of patients enrolled in randomized trials, their comparative effectiveness in real-world settings is…
  • 2016 American Transplant Congress

    Down-Regulated of Circulating miR-29b, miR-185 and NR_073415.2 in Post-Transplanted Patients with Cytomegalovirus Infection May Serve as Novel Biomarkers for Early Diagnosis.

    A. Yang, W. Ju, Z. Guo, C. Wu, J. Lin, M. Chen, R. Deng, E. Chen, Y. Gao, X. Zhu, X. He.

    Organ Transplantation Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

    Aims: Mortality of CMV infection in post-transplanted patients was quite high, which severely influencing the long-term survival of recipients. For giving them early treatment and…
  • 2016 American Transplant Congress

    Risk Factors for the Development of CMV Viremia in a Cohort of Morbidly Obese Kidney Transplant Recipients Under Low Dose Valganciclovir Prophylaxis.

    J. Thielke,1 N. Jasiak,1 N. Hilal,1 S. Salah,1 E. Benedetti,2 P. West-Thielke.2

    1Pharmacy Practice, Univ of IL-Chicago Medical Center, Chicago, IL; 2Dept of Surgery, Univ of IL-Chicago Medical Center, Chicago, IL.

    Background: The rate of Cytomegalovirus infections in kidney transplant recipients drastically diminished with the advent of oral ganciclovir and subsequently valganciclovir. However it continues to…
  • 2016 American Transplant Congress

    Implementation of a Risk Stratified Approach for Prevention of Hepatitis B Reactivation Post Kidney Transplant.

    M. Cote,1 M. Pavlakis,2 J. Ethridge,1 C. Currier,2 M. Curry,2 E. Khankin,2 F. Cardarelli,2 K. Richards,1,2 C. Rogers.1,2

    1Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston; 2Transplant Institute, Beth Israel Deaconess Medical Center, Boston.

    A large percentage of patients with end stage renal disease are known to be Hepatitis B virus (HBV) positive. A 2015 consensus guideline on use…
  • 2016 American Transplant Congress

    Development of a Sequencing-Based Cytomegalovirus UL55 Glycoprotein B (gB) Genotyping Assay.

    S. Cowden, K. Grantham, I. Caton, J. Hester, M. Altrich, S. Kleiboeker.

    Viracor-IBT Laboratories, Lee's Summit, MO.

    Background: Human cytomegalovirus (hCMV) is an important agent of serious viral infection in the solid organ transplant and allogeneic hematopoietic stem cell transplant populations. Severe…
  • 2016 American Transplant Congress

    CMV Monitoring Reduces Risk of Clinical Complications in Kidney Transplant Recipients.

    A. Gilbert, M. Cooper, J. Verbesey, R. Ghasemian, P. Abrams, J. Moore, M. Grafals, J. Chahine, S. Punnett, E. Hall, I. Anzak, B. Javaid.

    MedStar Georgetown Transplant Institute, Georgetown University School of Medicine, Washington, DC.

    Objective: Review the advantages of CMV viral load monitoring in preventing CMV associated complications in kidney transplant recipientsMethods: All individuals who underwent a kidney transplant…
  • 2016 American Transplant Congress

    Hepatitis B Reactivation Among Non-Liver Solid Organ Transplant Recipients.

    A. Gonzalez, F. Forouton, A. Humar, S. Husain.

    Multi-Organ Transplant Program, Transplant Infectious Diseases, University Health Network, University of Toronto, Toronto, ON, Canada.

    IntroductionThe purpose of this study was to evaluate the incidence of post-transplant hepatitis B (HBV) reactivation in patients who have previously cleared hepatitis B surface…
  • « Previous Page
  • 1
  • …
  • 1260
  • 1261
  • 1262
  • 1263
  • 1264
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences